Separate terms with OR to return results that match either term.
 
Clear All
10,000 Matching Results — Export these results
Click column titles once to sort ascending, and twice to sort descending.
Show Entries
NDC-11 (Package) NDC-9 (Product) Generic Name Brand Name Strength SEER*Rx Category Major Class Minor Class Administration Route Package Effective Date Package Discontinuation Date (Ascending) Status
00603-5336-32 00603-5336 Prednisone Prednisone 2.5 mg/1 Hormonal Therapy Adrenal Glucocorticoid Corticosteroid Oral Dec. 21, 2004 July 14, 2017 In Use
00603-5337-28 00603-5337 Prednisone Prednisone 5.0 mg/1 Hormonal Therapy Adrenal Glucocorticoid Corticosteroid Oral July 12, 2002 July 14, 2017 In Use
00603-5339-15 00603-5339 Prednisone Prednisone 20.0 mg/1 Hormonal Therapy Adrenal Glucocorticoid Corticosteroid Oral Feb. 12, 2003 July 14, 2017 In Use
00603-5339-31 00603-5339 Prednisone Prednisone 20.0 mg/1 Hormonal Therapy Adrenal Glucocorticoid Corticosteroid Oral Feb. 12, 2003 July 14, 2017 In Use
70518-0183-00 70518-0183 Ondansetron Ondansetron 2.0 mg/mL Ancillary Therapy Antiemetic 5HT3 Receptor Antagonist Intramuscular, Intravenous Jan. 27, 2017 July 31, 2017 No Longer Used
25021-0209-50 25021-0209 Gemcitabine Hydrochloride Gemcitabine 1.0 g/25mL Chemotherapy Antimetabolite Pyrimidine Analog Intravenous July 25, 2011 July 31, 2017 No Longer Used
00603-1147-56 00603-1147 Dexamethasone Dexamethasone 0.5 mg/5mL Hormonal Therapy Adrenal Glucocorticoid Corticosteroid Oral May 11, 2011 July 31, 2017 No Longer Used
41616-0485-08 41616-0485 Bicalutamide Bicalutamide 50.0 mg/1 Hormonal Therapy Androgen Receptor Inhibitor Non-Steroidal Oral July 7, 2009 July 31, 2017 No Longer Used
41616-0485-18 41616-0485 Bicalutamide Bicalutamide 50.0 mg/1 Hormonal Therapy Androgen Receptor Inhibitor Non-Steroidal Oral July 7, 2009 July 31, 2017 No Longer Used
41616-0485-83 41616-0485 Bicalutamide Bicalutamide 50.0 mg/1 Hormonal Therapy Androgen Receptor Inhibitor Non-Steroidal Oral July 7, 2009 July 31, 2017 No Longer Used
41616-0485-88 41616-0485 Bicalutamide Bicalutamide 50.0 mg/1 Hormonal Therapy Androgen Receptor Inhibitor Non-Steroidal Oral July 7, 2009 July 31, 2017 No Longer Used
25021-0212-50 25021-0212 Oxaliplatin Oxaliplatin 5.0 mg/mL Chemotherapy Alkylating Agent Platinum Compound Intravenous Aug. 9, 2012 July 31, 2017 No Longer Used
50090-1715-00 50090-1715 Dexamethasone Sodium Phosphate Dexamethasone Sodium Phosphate 4.0 mg/mL Hormonal Therapy Adrenal Glucocorticoid Corticosteroid Intramuscular, Intravenous Feb. 26, 2015 July 31, 2017 No Longer Used
50090-1892-00 50090-1892 Ondansetron Hydrochloride Ondansetron Hydrochloride 2.0 mg/mL Ancillary Therapy Antiemetic 5HT3 Receptor Antagonist Intravenous June 22, 2015 July 31, 2017 No Longer Used
55154-0328-08 55154-0328 Ondansetron Ondansetron 4.0 mg/1 Ancillary Therapy Antiemetic 5HT3 Receptor Antagonist Oral June 25, 2007 July 31, 2017 No Longer Used
45963-0734-74 45963-0734 Docetaxel Docetaxel 20.0 mg/mL Chemotherapy Antimitotic Agent Taxane Intravenous Sept. 1, 2014 July 31, 2017 In Use
00074-6463-32 00074-6463 Cyclosporine Modified Gengraf 25.0 mg/1 Ancillary Therapy Immunomodulator Calcineurin Inhibitor Oral May 24, 2010 Aug. 31, 2017 No Longer Used
00069-9141-11 00069-9141 Docetaxel Docetaxel 20.0 mg/2mL Chemotherapy Antimitotic Agent Taxane Intravenous June 23, 2014 Aug. 31, 2017 No Longer Used
00069-9142-11 00069-9142 Docetaxel Docetaxel 80.0 mg/8mL, 80.0 mg/8mL Chemotherapy Antimitotic Agent Taxane Intravenous June 23, 2014 Aug. 31, 2017 No Longer Used
00173-0821-01 00173-0821 Ofatumumab Arzerra 20.0 mg/mL Immunotherapy Monoclonal Antibody CD20 Intravenous July 22, 2011 Aug. 31, 2017 No Longer Used
00173-0821-02 00173-0821 Ofatumumab Arzerra 20.0 mg/mL Immunotherapy Monoclonal Antibody CD20 Intravenous July 22, 2011 Aug. 31, 2017 No Longer Used
00173-0821-33 00173-0821 Ofatumumab Arzerra 20.0 mg/mL Immunotherapy Monoclonal Antibody CD20 Intravenous July 22, 2011 Aug. 31, 2017 No Longer Used
00078-0341-61 00078-0341 Octreotide Acetate Sandostatin LAR Depot Hormonal Therapy Somatostatin Analog Nov. 1, 1988 Aug. 31, 2017 No Longer Used
00078-0342-61 00078-0342 Octreotide Acetate Sandostatin LAR Depot Hormonal Therapy Somatostatin Analog Nov. 1, 1988 Aug. 31, 2017 No Longer Used
00078-9342-61 00078-9342 Octreotide Acetate Sandostatin LAR Depot Demonstration Kit Hormonal Therapy Somatostatin Analog Nov. 1, 1988 Aug. 31, 2017 No Longer Used
24987-0111-14 24987-0111 Nilutamide Nilandron 150.0 mg/1 Hormonal Therapy Androgen Receptor Inhibitor Non-Steroidal Oral July 15, 2013 Aug. 31, 2017 No Longer Used
63323-0172-45 63323-0172 Carboplatin Carboplatin 10.0 mg/mL Chemotherapy Alkylating Agent Platinum Compound Intravenous Sept. 15, 2009 Aug. 31, 2017 In Use
50090-1600-03 50090-1600 ondansetron hydrochloride Ondansetron 4.0 mg/1 Ancillary Therapy Antiemetic 5HT3 Receptor Antagonist Oral Jan. 5, 2015 Aug. 31, 2017 In Use
76126-0075-01 76126-0075 Mesna Mesna 100.0 mg/mL Ancillary Therapy Chemoprotective Detoxifying Agent Intravenous July 19, 2014 Sept. 1, 2017 No Longer Used
00074-6479-32 00074-6479 Cyclosporine Modified Gengraf 100.0 mg/1 Ancillary Therapy Immunomodulator Calcineurin Inhibitor Oral May 24, 2010 Sept. 16, 2017 No Longer Used
42195-0105-06 42195-0105 Dexamethasone Decadron DP 1.5 mg/1 Hormonal Therapy Adrenal Glucocorticoid Corticosteroid Oral Sept. 11, 2017 Sept. 25, 2017 No Longer Used
42195-0105-12 42195-0105 Dexamethasone Decadron DP 1.5 mg/1 Hormonal Therapy Adrenal Glucocorticoid Corticosteroid Oral Sept. 11, 2017 Sept. 25, 2017 No Longer Used
66992-0015-01 66992-0015 Dexamethasone Decadron 1.5 mg/1 Hormonal Therapy Adrenal Glucocorticoid Corticosteroid Oral Sept. 11, 2017 Sept. 25, 2017 No Longer Used
00173-0569-00 00173-0569 Ondansetron Hydrochloride Zofran ODT 4.0 mg/1 Ancillary Therapy Antiemetic 5HT3 Receptor Antagonist Oral March 1, 1999 Sept. 30, 2017 No Longer Used
25021-0202-15 25021-0202 Carboplatin Carboplatin 10.0 mg/mL Chemotherapy Alkylating Agent Platinum Compound Intravenous Oct. 31, 2013 Sept. 30, 2017 No Longer Used
00093-0784-05 00093-0784 Tamoxifen Citrate Tamoxifen Citrate 10.0 mg/1 Hormonal Therapy Selective Estrogen Receptor Modulator (SERM) Oral Jan. 9, 2008 Sept. 30, 2017 No Longer Used
51991-0749-33 51991-0749 Dutasteride Dutasteride 0.5 mg/1 Ancillary Therapy Protective Agent 5-alpha Reductase Inhibitor Oral Nov. 20, 2015 Sept. 30, 2017 No Longer Used
00088-1206-32 00088-1206 Dolasetron mesylate Anzemet 100.0 mg/5mL Ancillary Therapy Antiemetic 5HT3 Receptor Antagonist Intravenous Sept. 11, 1997 Sept. 30, 2017 No Longer Used
76237-0227-30 76237-0227 Prednisone Prednisone 5.0 mg/1 Hormonal Therapy Adrenal Glucocorticoid Corticosteroid Oral Oct. 12, 2011 Sept. 30, 2017 No Longer Used
76237-0228-30 76237-0228 Prednisone Prednisone 10.0 mg/1 Hormonal Therapy Adrenal Glucocorticoid Corticosteroid Oral Dec. 20, 2011 Sept. 30, 2017 No Longer Used
43063-0201-01 43063-0201 Estradiol Estradiol 2.0 mg/1 Hormonal Therapy Estrogen Oral Dec. 10, 2009 Oct. 2, 2017 No Longer Used
43063-0201-30 43063-0201 Estradiol Estradiol 2.0 mg/1 Hormonal Therapy Estrogen Oral Dec. 10, 2009 Oct. 2, 2017 No Longer Used
43063-0201-90 43063-0201 Estradiol Estradiol 2.0 mg/1 Hormonal Therapy Estrogen Oral Dec. 10, 2009 Oct. 2, 2017 No Longer Used
60429-0272-05 60429-0272 Flutamide Flutamide 125.0 mg/1 Hormonal Therapy Androgen Receptor Inhibitor Non-Steroidal Oral Sept. 18, 2001 Oct. 10, 2017 No Longer Used
00409-4755-11 00409-4755 Ondansetron Ondansetron 2.0 mg/mL Ancillary Therapy Antiemetic 5HT3 Receptor Antagonist Intramuscular, Intravenous Oct. 24, 2014 Oct. 16, 2017 In Use
00409-4755-12 00409-4755 Ondansetron Ondansetron 2.0 mg/mL Ancillary Therapy Antiemetic 5HT3 Receptor Antagonist Intramuscular, Intravenous Oct. 24, 2014 Oct. 16, 2017 In Use
67979-0001-02 67979-0001 Valrubicin Valstar 40.0 mg/mL Chemotherapy Antitumor Antibiotic Anthracycline Intravesical Oct. 1, 1998 Oct. 17, 2017 In Use
00015-1911-13 00015-1911 Ixabepilone Ixempra Chemotherapy Antitumor Antibiotic Epothilones Intravenous Oct. 16, 2007 Oct. 31, 2017 No Longer Used
61703-0341-06 61703-0341 Vinorelbine Vinorelbine 10.0 mg/mL Chemotherapy Antimitotic Agent Vinca Alkaloid Intravenous April 9, 2007 Oct. 31, 2017 No Longer Used
00009-1111-01 00009-1111 Irinotecan Hydrochloride Camptosar 20.0 mg/mL Chemotherapy Topoisomerase I Inhibitor Camptothecin Analogs Intravenous June 14, 1996 Oct. 31, 2017 In Use

Found 10,000 results in 4 milliseconds — Export these results